Literature DB >> 889494

Amaurosis fugax from disease of the external carotid artery.

M D Burnbaum, J B Selhorst, J W Harbison, J J Brush.   

Abstract

Three patients with proved internal carotid artery occlusion and diseased external carotid artery or common carotid artery had amaurosis fugax. Evidence for retinal embolization through external carotid collaterals is retinal emboli and infarction after carotid artery manipulation, amaurosis during external carotid angiography, and relief of amaurosis by endarterectomy of this vessel. The abundance of external carotid collaterals, their size, and natural incidence are discussed. Reports clinically support embolization to the central retinal artery and ophthalmic artery through these collaterals.

Entities:  

Mesh:

Year:  1977        PMID: 889494     DOI: 10.1001/archneur.1977.00500210034004

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  5 in total

1.  Cerebro-retinal ischemia after bilateral occlusion of internal carotid artery. A study with prospective follow-up.

Authors:  J Bogousslavsky; F Regli
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

2.  Amaurosis fugax: some aspects of management.

Authors:  P J Parkin; B E Kendall; J Marshall; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-01       Impact factor: 10.154

3.  Follow-up of patients with proved occluded internal carotid artery. Clinical and angiographic correlation.

Authors:  G B Bradac; B Kaden; F Nüssel; R Oberson
Journal:  Neuroradiology       Date:  1983       Impact factor: 2.804

4.  The so-called atheromatous pseudoocclusion of the internal carotid artery. A diagnostic and therapeutical challenge.

Authors:  E B Ringelstein; E Berg-Dammer; H Zeumer
Journal:  Neuroradiology       Date:  1983       Impact factor: 2.804

5.  Occlusion of internal carotid artery. Further clinical angiographic, and therapeutic considerations.

Authors:  G B Bradac; B Kaden; F Oppel; A Hirner
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.